Nuwellis (NUWE) EPS (Diluted) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Nuwellis (NUWE) EPS (Diluted) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.96% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 56.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.29% |
| Mar 31, 2026 | -217.56% |
| Dec 31, 2025 | -217.16% |
| Sep 30, 2025 | -67.85% |
| Jun 30, 2025 | -223.39% |
| Mar 31, 2025 | 96.73% |
| Dec 31, 2024 | 99.22% |
| Sep 30, 2024 | 102.76% |
| Jun 30, 2024 | 85.25% |
| Mar 31, 2024 | 89.53% |
| Dec 31, 2023 | -162.36% |
| Sep 30, 2023 | 95.09% |
| Jun 30, 2023 | 91.06% |
| Mar 31, 2023 | 86.48% |
| Dec 31, 2022 | 279.30% |
| Sep 30, 2022 | 60.68% |
| Jun 30, 2022 | 57.84% |
| Mar 31, 2022 | 65.65% |
| Dec 31, 2021 | -128.47% |
| Sep 30, 2021 | 54.95% |